Home > News > Industry > Medical Devices News > CDSCO nod to medical...

CDSCO nod to medical smartwatch CardiacSense

"CardiacSense is one such device that will enable doctors and hospitals to monitor patients 24/7 who have recently undergone major surgeries or those suffering from chronic heart disease or organ failure," Pankaj Balwani, Founder & CEO of Xplore Health said.

By - Ruchika Sharma
Published On 2023-02-18 05:30 GMT   |   Update On 2023-02-18 05:30 GMT

New Delhi: Homegrown MedTech solutions provider Xplore Health on Thursday announced that it received approval from the Indian Regulatory Authority CDSCO (Central Drug Standard Control Organisation) under the Health Ministry of India for its aspirational medical smartwatch "CardiacSense".The approval came ahead of its commercial launch in collaboration with Israeli Medtech company...

Login or Register to read the full article
Register Now

New Delhi: Homegrown MedTech solutions provider Xplore Health on Thursday announced that it received approval from the Indian Regulatory Authority CDSCO (Central Drug Standard Control Organisation) under the Health Ministry of India for its aspirational medical smartwatch "CardiacSense".

The approval came ahead of its commercial launch in collaboration with Israeli Medtech company CardiacSense Ltd. The product has already been approved by the US Food and Drug Administration (FDA) and is the only medical watch to demonstrate accuracies higher than FDA-set Thresholds, making it one of the only approved Medical Watch, according to the company.
"CardiacSense technology is designed to ensure that one is able to continuously monitor their Vital signs and whenever there is a notification raised by the watch for increased or decreased heart rates or for Arrhythmias, the watch prompts the user to take an ECG and shares it instantly with the doctor for immediate advise," Pankaj Balwani, Founder & CEO of Xplore Health, said in a statement.
"CardiacSense is one such device that will enable doctors and hospitals to monitor patients 24/7 who have recently undergone major surgeries or those suffering from chronic heart disease or organ failure," he added.
After receiving approval from India, CardiacSense is now available in over 40 countries, including the US, all European countries, Australia, New Zealand, and many other South American countries, said the company.

Read also: AstraZeneca India gets CDSCO nod for Durvalumab to treat biliary tract cancer

Tags:    
Article Source : IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Biosense Webster unveils new version of CARTO 3 Electro-Anatomical Mapping System
DoP Secretary launches MEDITECH STACKATHON 2024 in collaboration with CII at New Delhi
Medtronic gets USFDA approval for Inceptiv closed-loop spinal cord stimulator for chronic pain
IIT Madras unveils India's first mobile Medical Devices Calibration facility
Dr Reddys Labs rolls out drug-free migraine management device Nerivio in Germany
Roche gets USFDA approval for molecular test to screen for malaria in blood donors
Boston Scientific secures USFDA okay for AGENT Drug-Coated Balloon to treat coronary in-stent restenosis
Medtronic inaugurates RnD center outside US in Hyderabad